Home-Based Care M&A: Why Investors Are Paying Billions Despite Fewer Deals
Discover why home-based care deal volume dropped in Q2 2026 while mega-acquisitions like TEAM Services Group and Enhabit signal strong investor confidence.
Mega-Deals Define a Quiet Quarter
While the total number of transactions in the home-based care sector dipped during the second quarter of 2026, the industry witnessed a surge in high-value activity. Data from the Mertz Taggart Q2 2026 home-based care M&A report reveals that investors are prioritizing scale, evidenced by two record-breaking transactions. General Atlantic finalized a $3 billion acquisition of TEAM Services Group, while Kinderhook Industries secured Enhabit in a deal valued at $1.1 billion.
Overall, 16 transactions across hospice, home health, and home care sectors reached completion during the quarter, with two additional agreements announced but still pending. Despite the lower deal count, the financial commitment remains robust as private equity sponsors continue to deploy significant capital.
The Complexity of Modern Transactions
Cory Mertz, managing partner at Mertz Taggart, suggests that the cooling deal volume may be linked to a shifting regulatory landscape. Increased scrutiny—including hospice 36-month rules, enrollment moratoriums, and heightened fraud enforcement—has introduced new layers of complexity for buyers and sellers alike. "The count came down this quarter, and it’s fair to ask whether the regulatory environment is part of it," Mertz noted. However, he emphasized that the sheer volume of capital involved tells a more optimistic story, as sponsors seek to return value to limited partners following extended holding periods.
Platform Acquisitions Take Center Stage
In a shift from previous years, the market favored platform acquisitions over add-on deals. The composition of Q2 activity included six new private equity entries, four sponsor-backed strategic add-ons, one public-company buyout, and five acquisitions by independent or post-acute entities.
Home health saw six deals close, a slight decline from the eight recorded in each of the two previous quarters. The acquisition of Enhabit stood out as a clear highlight, trading at a 10.2x EBITDA multiple on $108 million in earnings. This represented a 24% premium over the company’s undisturbed share price and a 34% increase compared to its 60-day average. "The Enhabit deal is a good reminder of why we don’t lead with multiples," Mertz explained. Other notable activity included Lucent Home Health’s purchase of Chambers Home Health Agency of Northeast Texas and the acquisition of Chant Healthcare by Superior Health Holdings.
Non-Medical Home Care Momentum
Non-medical home care accounted for eight completed deals in Q2. Beyond the massive TEAM Services Group transaction, the market saw Warburg Pincus initiate a platform investment in Cornerstone Caregiving. Meanwhile, Addus HomeCare Corporation expanded its footprint by acquiring HomeCourt Home Care, and Care Advantage grew its portfolio through the purchase of First Priority Home Care.
For those looking to exit, Mertz emphasizes that preparation is paramount. "Diligence around billing and compliance has only intensified—especially in the enhanced-oversight states—and the sellers who invest early in getting their house in order are the ones who hold their value all the way through to close," he concluded.
Recent Developments
The home-based care industry is currently navigating a complex period of regulatory shifts and high-value financial movements. This breaking news highlights how top-tier firms are prioritizing platform scalability in the latest updates to their portfolios. You can follow all developments instantly on CareChronicle.net.
Related Topics
🔹 Home Health Care 🔹 Private Equity 🔹 Mergers and Acquisitions 🔹 Healthcare Compliance 🔹 Hospice Care 🔹 Market Trends 🔹 Investor Relations
Caregiving-news News
Our Caregiving-news section provides the latest updates on the business and operational side of the home care industry. We offer live insights into market shifts and breaking news that affects providers, patients, and investors on CareChronicle.net.
Frequently Asked Questions
What caused the decline in deal volume during Q2 2026?
Industry experts point to a more complex regulatory environment, including increased fraud oversight and new enrollment rules, which makes closing deals more challenging. Despite this, the total dollar value of deals remains high due to large-scale platform acquisitions.
Why was the Enhabit acquisition considered significant?
Although the 10.2x EBITDA multiple seemed standard, the deal offered a 24% premium over the undisturbed share price. This demonstrated strong investor interest in the value of the platform beyond simple valuation multiples.
What should sellers focus on to ensure a successful deal?
Sellers must prioritize early preparation regarding billing and compliance documentation. Companies that maintain clean records, particularly in states with enhanced regulatory oversight, are better positioned to protect their valuation during the closing process.